Search

The Centers for Medicare & Medicaid Services’ (CMS) home health, hospice, home infusion therapy, home IVIG, and IRF benefits require constant monitoring of payment policy—and revisions, as needed—to ensure they are working as intended. This enables…

This report from Abt Global for Medicare highlights changes to the home infusion therapy (HIT) benefit as it transitioned to a permanent benefit.

To help patients and their families find high quality home health and hospice care, the Centers for Medicare & Medicaid Services (CMS) requires support for developing and maintaining patient assessment tools and quality measures for its Home Health and…

Changes in the complex prospective payment system (PPS) for home health agencies (HHAs) may have led to HHA behavior changes that thwarted the modifications’ goals. As a result, the Centers for Medicare & Medicaid Services (CMS) wanted an assessment of…

When individuals need long-term care, information on provider quality is critical to making an informed choice. The major ongoing challenge in the project is preparing the monthly updates to Care Compare and its Five-Star Quality Rating System to support…

Infectious diseases can spread quickly through nursing homes, leading to high morbidity and mortality in this vulnerable population. The COVID-19 pandemic underscored this, causing over 1.7 million SARS-CoV-2 cases and almost 168,000 deaths among nursing…

Studies indicate that dementia care in the United States is, generally, impersonal and fragmented. Massachusetts requires long-term care facilities to provide dementia care training to direct-care workers. The intention of the regulation was to address…

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.